Re: 3600 patient years
|
9
|
Resverlogix Corp.
|
Feb 16, 2018 05:00PM
|
Re: 3600 patient years
|
5
|
Resverlogix Corp.
|
Feb 17, 2018 02:35PM
|
Re: 3600 patient years
|
11
|
Resverlogix Corp.
|
Feb 20, 2018 04:34PM
|
Re: Zenith Private placement??
|
1
|
Zenith Epigenetics
|
Feb 21, 2018 09:21AM
|
Re: AACR 2018
|
5
|
Zenith Epigenetics
|
Feb 21, 2018 11:38AM
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 21, 2018 05:45PM
|
Re: AACR 2018
|
4
|
Zenith Epigenetics
|
Feb 21, 2018 05:52PM
|
Re: AACR 2018
|
5
|
Zenith Epigenetics
|
Feb 22, 2018 10:34AM
|
Welcome to the party ABBV-744
|
6
|
Resverlogix Corp.
|
Feb 22, 2018 10:52AM
|
Re: News !!!
|
5
|
Resverlogix Corp.
|
Feb 26, 2018 09:43AM
|
Resverlogix Announces Sixth Positive Recommendation From DSMB For Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Feb 26, 2018 09:44AM
|
Re: News !!!
|
3
|
Resverlogix Corp.
|
Feb 26, 2018 11:00AM
|
Re: News !!!
|
|
Resverlogix Corp.
|
Feb 26, 2018 02:00PM
|
Re: News !!!
|
1
|
Resverlogix Corp.
|
Feb 26, 2018 02:04PM
|
Re: News !!!
|
2
|
Resverlogix Corp.
|
Feb 26, 2018 08:30PM
|
Re: News !!!
|
3
|
Resverlogix Corp.
|
Feb 27, 2018 06:58AM
|
Re: News !!!
|
4
|
Resverlogix Corp.
|
Feb 27, 2018 11:59AM
|
Resverlogix ACC 2018 Abstract
|
7
|
Resverlogix Corp.
|
Feb 27, 2018 02:22PM
|
Re: News !!!
|
3
|
Resverlogix Corp.
|
Feb 27, 2018 10:48PM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 28, 2018 03:21PM
|